Role of CtDNA in Bladder Cancer
Alexandra Drakaki, MD, PhD, explores circulating tumor DNA in bladder cancer, highlighting its potential as a biomarker.
Read MoreSelect Page
by Alexandra Drakaki, MD, PhD | Mar 2025
Alexandra Drakaki, MD, PhD, explores circulating tumor DNA in bladder cancer, highlighting its potential as a biomarker.
Read Moreby Gopalkumar Iyer, MD | Mar 2025
Gopalkumar Iyer, MD, explores the role of genomic alterations in predicting response to neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Read Moreby Bernard H. Bochner, MD, FACS | Mar 2025
Bernard H. Bochner, MD, FACS, examines the extent of lymph node dissection in bladder cancer surgery and its impact on oncologic outcomes.
Read Moreby Arlene O. Siefker-Radtke | Mar 2025
Arlene O. Siefker-Radtke, MD, explores the evolving role of erdafitinib in treating FGFR3-altered urothelial carcinoma.
Read Moreby Jennifer A. Linehan, MD | Mar 2025
Jennifer A. Linehan, MD, examines strategies for managing upper tract UTUC, highlighting diagnosis, staging, and treatment selection.
Read Moreby Piyush K. Agarwal | Mar 2025
Piyush K. Agarwal, MD, explores the evolving landscape of treatments for BCG-unresponsive bladder cancer.
Read Moreby Robert Dreicer, MD, MS, MACP, FASCO | Mar 2025
Robert Dreicer, MD, MS, MACP, FASCO, highlights the complexities of managing high-grade urothelial carcinoma of the upper tract.
Read Moreby Steven J. Frank, MD, FACR, FABS, FASTRO | Mar 2025
Steven J. Frank, MD, FACR, FABS, FASTRO, discusses advancements in MRI-assisted radiosurgery (MARS) for prostate cancer.
Read Moreby Parminder Singh, MD | Feb 2025
Parminder Singh, MD, explores the evolving treatment for bladder cancer, emphasizing advancements over the past decade.
Read Moreby Juan H. Chipollini, MD, FACS | Feb 2025
Juan H. Chipollini, MD, FACS, provides an in-depth analysis of bladder-preserving approaches for muscle-invasive bladder cancer (MIBC).
Read Moreby Parminder Singh, MD | Feb 2025
Parminder Singh, MD, examines bladder preservation strategies for muscle-invasive bladder cancer (MIBC).
Read Moreby Adam S. Kibel, MD | Feb 2025
Adam S. Kibel, MD, delves into strategies for prostate cancer detection, emphasizing the role of MRI and biomarkers in diagnostic accuracy.
Read More